AMRUTANJAN Intraday Analysis...

AMRUTANJAN Share Price

Open 632.00 Change Price %
High 636.45 1 Day -18.25 -2.85
Low 620.00 1 Week 27.80 4.68
Close 622.30 1 Month 89.70 16.84
Volume 30908 1 Year 216.65 53.41
52 Week High 661.30
52 Week Low 375.55
AMRUTANJAN Important Levels
Resistance 2 637.55
Resistance 1 631.27
Pivot 626.25
Support 1 613.33
Support 2 607.05
NSE INDIA Most Active Stocks
SUZLON 17.35 1.17%
ADANIPOWER 34.35 -11.35%
VISESHINFO 0.25 25.00%
ESL 5.95 -1.65%
ESL 5.95 -1.65%
ESL 5.95 -1.65%
ESL 5.95 -1.65%
AXISBANK 450.75 -6.83%
IDEA 71.50 3.10%
GMRINFRA 12.70 0.40%
More..
NSE INDIA Top Gainers Stocks
ATNINTER 0.25 25.00%
VISESHINFO 0.25 25.00%
ARSHIYA 40.20 20.00%
ICSA 3.35 19.64%
ICSA 3.35 19.64%
GPIL 102.70 18.25%
RUCHISOYA 27.20 13.10%
TARAPUR 6.55 12.93%
ELGIRUBCO 66.45 11.12%
PRAKASHSTL 1.50 11.11%
More..
NSE INDIA Top Losers Stocks
JAIHINDPRO 5.75 -11.54%
ADANIPOWER 34.35 -11.35%
FMNL 45.80 -9.84%
INVENTURE 17.80 -8.72%
PRECOT 69.70 -8.41%
MONNETISPA 25.85 -7.51%
SINTEX 82.70 -7.49%
MRPL 100.60 -7.49%
INDOTHAI 25.20 -7.01%
AXISBANK 450.75 -6.83%
More..

Amrutanjan Health Care Limited (NSE: AMRUTANJAN)

AMRUTANJAN Technical Analysis 5
As on 20th Jan 2017 AMRUTANJAN Share Price closed @ 622.30 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 465.72 & Strong Buy for SHORT-TERM with Stoploss of 550.48 we also expect STOCK to react on Following IMPORTANT LEVELS.
AMRUTANJAN Target for January
1st Target up-side 573.36
2nd Target up-side 605.25
3rd Target up-side 637.15
1st Target down-side 482.34
2nd Target down-side 450.45
3rd Target down-side 418.55
Amrutanjan Health Care Limited ( NSE INDIA Symbol : AMRUTANJAN )
Sector : Pharmaceuticals - Formulations And Other Stocks in Same Sector
JAGSNPHARM
37.65 -1.05 (-2.71 %)
LT : Buy
ST : Strong Buy
AMRUTANJAN
622.30 -18.25 (-2.85 %)
LT : Strong Buy
ST : Strong Buy
AMRUTANJAN Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
AMRUTANJAN Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals - Formulations
Industry
Offical website
AMRUTANJAN Address
AMRUTANJAN
N/A
AMRUTANJAN Latest News
CRISIL ratings for Indian debt instruments-Mar 17   Reuters   - 17th Mar 15
Director resigns from Amrutanjan Health Care Ltd   Equity Bulls   - 13th Mar 15
Amrutanjan Healthcare Oct—Dec quarter net soars 29.5%   Hindu Business Line   - 05th Feb 15
Amrutanjan Health Care: Board declares interim dividend   Moneycontrol.com   - 05th Feb 15
Buy Amrutanjan Health Care Ltd. with a target of Rs 550: Prakash Gaba   Economic Times   - 08th Dec 14
Amrutanjan Health Care zooms over 50% in three days   Business Standard   - 21st Nov 14
CRISIL ratings for Indian debt instruments-Jan 1   Reuters   - 01st Jan 14
Amrutanjan Health Care (Rs 131): BUY   Hindu Business Line   - 25th Dec 13
Amrutanjan Health Care to split face value of share to   pharmabiz.com   - 11th Oct 12
Buy Amrutanjan Health; target Rs 870: Firstcall Research   Moneycontrol.com   - 08th Oct 12
Interactive Technical Analysis Chart Amrutanjan Health Care Limited ( AMRUTANJAN NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Amrutanjan Health Care Limited
AMRUTANJAN Business Profile
Amrutanjan Health Care Limited started in the year 1893 by the social reformer, journalist and freedom fighter, Desodharaka Sri.Nageswara Rao Pantulu Garu, today Amrutanjan is one of the household names in India.The company’s current offerings have been segregated to 3 sub brands: Kick Out Pain for pain management, Relief for congestion management and Purity for hygiene products. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc.Company is having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Limited having holding stake 99.80% & Amrutanjan Finance Limited, having holding stake is 57.26%. Amrutanjan company has reported a standalone sales of Rs 33.44 crore and a Net Profit of Rs 2.98 crore for the quarter ended September 2013. The Registered office is at No. 103 (Old No.42-45), Luz Church Road, Mylapore, Chennai, Tamil Nadu - 600004.